TOVX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Theriva Biologics announces publication in Nature Medicine of VIRAGE Phase 2b results for VCN-01 in metastatic pancreatic cancerSep 30, 2026
- Theriva Biologics dosed the first patient in the VIRAGE2 Phase 2a trial of VCN-01 for metastatic pancreatic cancerAug 6, 2026
- Theriva Biologics received regulatory authorization to proceed with the VIRAGE2 Phase 2a trial of VCN-01 in metastatic pancreatic cancerJul 8, 2026
- Theriva Biologics reported Phase 1 results for VCN-01 in head and neck cancer published in Clinical Cancer ResearchJun 11, 2026
- Theriva Biologics reported a positive end-of-Phase 2 FDA meeting on the Phase 3 design of VCN-01 for metastatic pancreatic cancerMar 23, 2026